The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

G Van Assche, A Dignass, W Reinisch… - Journal of Crohn's …, 2010 - academic.oup.com
Fistulating Crohn's disease (CD) comprises fistulae arising in the perianal area, together
with those communicating between the intestine and other organs or the abdominal wall …

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

L Beaugerie, N Brousse, AM Bouvier, JF Colombel… - The Lancet, 2009 - thelancet.com
Background Reports of an increased risk of lymphoproliferative disorders in patients
receiving thiopurines for inflammatory bowel disease are controversial. We assessed this …

Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines

J Panes, Y Bouhnik, W Reinisch, J Stoker… - Journal of Crohn's …, 2013 - academic.oup.com
The management of patients with IBD requires evaluation with objective tools, both at the
time of diagnosis and throughout the course of the disease, to determine the location …

Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped

E Louis, JY Mary, G Vernier–Massouille, JC Grimaud… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: It is important to determine whether infliximab therapy can be safely
interrupted in patients with Crohn's disease who have undergone a period of prolonged …

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

D Laharie, A Bourreille, J Branche, M Allez, Y Bouhnik… - The Lancet, 2012 - thelancet.com
Background Ciclosporin and infliximab are potential rescue treatments to avoid colectomy in
patients with acute severe ulcerative colitis refractory to intravenous corticosteroids. We …

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine

Y Bouhnik, G Scemama, R Taï, C Matuchansky… - The Lancet, 1996 - Elsevier
Background Crohn's ulcerative gastrointestinal disease is presently managed through a
variety of medical interventions, including—according to severity of illness—anti …

[HTML][HTML] The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel …

Y Bouhnik, L Raskine, G Simoneau, E Vicaut… - The American journal of …, 2004 - Elsevier
ABSTRACT Background Nondigestible carbohydrates (NDCHs) are fermented in the colon,
where they can selectively promote the growth of bifidobacteria. Objective Our aim was to …

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID …

P Marteau, M Lémann, P Seksik, D Laharie… - Gut, 2006 - gut.bmj.com
Background and aims: Early endoscopic recurrence is frequent after intestinal resection for
Crohn's disease. Bacteria are involved, and probiotics may modulate immune responses to …

[HTML][HTML] Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans

Y Bouhnik, K Vahedi, L Achour, A Attar, J Salfati… - The Journal of …, 1999 - Elsevier
Short-chain fructo-oligosaccharides (SC-FOS) are a mixture of oligosaccharides consisting
of glucose linked to fructose units (Gf n; n=≤ 4), which are not digested in the human small …

Resistance of t (11; 18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

H Liu, A Ruskon-Fourmestraux, A Lavergne-Slove… - The Lancet, 2001 - thelancet.com
30% of gastric mucosa-associated lymphoid tissue (MALT) lymphoma associated with
Helicobacter pylori do not regress after antibiotic therapy. Regression can be assessed only …